Sign in
CompletedNo phase

Neurofeedback for Borderline Personality Disorder

Key facts

Who runs it
Kymberly Young
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Completed
People taking part
30 people enrolled
Started
2 Sept 2022
Ended
30 Apr 2026
Type of study
Interventional
Treatments tested
  • Amygdala Neurofeedback
Record updated
5 May 2026

Who can take part

Age
18 years to 55 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • right-handed adults (ages 18 - 55) with a primary diagnosis of Borderline Personality Disorder according to diagnostic criteria in the Structured Interview for DSM Personality Disorders
  • must be able to give written informed consent prior to participation
  • unmedicated or stable on an SSRI antidepressant regime (at least 3 weeks to ensure symptoms are stable)
  • English speaking

Who cannot take part

  • current (within 3 weeks of testing) use of any antipsychotics, benzodiazepines, beta-blockers, or other medications (except SSRI antidepressants) likely to influence cerebral blood flow. Effective medications will not be discontinued for the purposes of the study. Inclusion of patients on stable antidepressant medications was decided in order to allow generalization towards a real world population
  • have a clinically significant or unstable cardiovascular, pulmonary, endocrine, neurological, gastrointestinal illness or unstable medical disorder
  • Current moderate or severe DSM-V alcohol or substance use disorder, with the exception of nicotine or caffeine. Clinician will access subjects' alcohol and substance use on a case-by-case to determine whether specific cases of mild alcohol or substance use would also interfere with the effects of the intervention
  • have a history of traumatic brain injury
  • have a DSM-5 diagnosis of psychotic or organic mental disorder
  • are unable to complete MRI scan due to claustrophobia or general MRI exclusions (e.g., shrapnel inside body)
  • are currently pregnant or breast feeding
  • are unable to complete questionnaires written in English
  • have any eye problems or difficulties in corrected vision
  • Serious suidicial ideation

Where in United States

  • University of PittsburghPittsburgh, United States

About the trial

What the trial wants to find out

The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as an intervention for borderline personality disorder.

The group in the trial

  • Amygdala NeurofeedbackTreatment being tested

    Participants will undergo real-time fMRI neurofeedback training to increase their amygdala response while recalling positive autobiographical memories. 2 sessions will occur within a one week period.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Amygdala rtfMRI Neurofeedback for Borderline Personality Disorder
Record updated
5 May 2026